Immunotherapies Scientists at the Institute for Systems Biology (ISB) reveal how T cells "decide" their fate in fighting ...

This commentary is a repost from "Sex on Wednesdays" by Martha Kempner on Substack. Find her other articles on The Queen...

Kairos Pharma (NYSE American: KAPA) presented preclinical data on its GITR agonist, KROS 101, during the plenary session of the AACR-JCA conference.

These include some obvious mechanical activities such as endocytosis, cell motility and membrane resealing, but also others, such as replication and transcription. Taking the motor proteins as an ...

A treatment for patients living with advanced non-small cell lung cancer (NSCLC) who failed two or more standard-of-care (SOC ...

Personalized medicine advances as autologous cell therapy grows, leveraging refined cell collection, improved processing ...

This study provides a valuable new resource to investigate the molecular basis of the particular features characterizing the pipefish embryo. The authors found both unique and shared gene expression ...

the Ohio Center for Ecology and Evolutionary Studies (OCEES), the Quantitative Biology Institute, the Infectious and Tropical Disease Institute, and more. The Cell, Developmental and Molecular Biology ...

Its application in research laboratories facilitates the study of stem cell biology and the development of new therapeutic ...

Understanding how cells transform into specialized types during human development is a central challenge in biology. This complex process, known as cell differentiation, holds the key to ...

The company is headquartered in Boston, Massachusetts, the US. For a complete picture of ANK-101’s drug-specific PTSR and LoA scores, buy the report here. GlobalData, the leading provider of industry ...